Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Society for Biomolecular Sciences and Association for Laboratory Automation to Combine Forces

By LabMedica International staff writers
Posted on 18 May 2010
For most of the past two years, the leaders of the Society for Biomolecular Sciences (SBS; Danbury, CT, USA) and the Association for Laboratory Automation (ALA; Geneva, IL, USA) have been organizing a merger to unite their scientific societies as one inclusive organization--the Society for Laboratory Automation and Screening (SLAS). More...


As of May 5, 2010, both memberships officially authorized the merger with more than 95% of the votes cast in favor. SBS and ALA will now unite as individual sections of SLAS. Each section will continue to pursue their current mission while collectively addressing the SLAS mission, which is to provide forums for education and information exchange to encourage the study of and improve the science and practice of laboratory automation and screening.

Under the SLAS umbrella, the SBS and ALA sections each will preserve SBS's and ALA's former identities and specialized educational pursuits. Moreover, both will benefit from the expanded scope, international influence, and enhanced program and service offerings that the unified organization will provide.

Inaugural SLAS president Michelle Palmer, Ph.D., Broad Institute of the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA) and Harvard University (Cambridge, MA, USA) said, "SLAS will become the premier international community dedicated to advancing scientific research and discovery through laboratory automation and screening technology. We are extremely excited and gratified that the members of both SBS and ALA supported the merger so enthusiastically. We will celebrate today--and then get to work tomorrow. We are now faced with one of the most important steps in the evolution of our organizations. Our current objective is to bring the two organizations together over a transition period of about a year. And, of course, we will be looking for members to join us and contribute as volunteers on many of the new SLAS committees and working groups.”

Dr. Palmer in addition said, "The transition phase will take place throughout 2011, with SLAS supporting two annual conferences, one representing the original SBS section and another representing the original ALA section. Planned symposia, journals, and virtual services will continue. During this transition period, the new SLAS Board of Directors, together with the leadership of the SBS and ALA sections, will be working to develop and unveil a longer range strategy and educational vision for all activities under the SLAS umbrella.”

According to SLAS chief executive officer Greg Dummer, there is much on the horizon in the near term. "We will laser-in on the fundamentals of organizational transition throughout the next year to ensure the members of both organizations feel welcome in their new society, and continue to receive valued member benefits and services,” said Mr. Dummer. "Our objective right now is to be ready for business as a united new entity sometime later this year. With the traditional SBS and ALA conferences and exhibitions set for the first quarter of 2011, we have to maintain a high level of focus and determination; and we must look to appropriately blend some aspects of SLAS into each of these events.”

Mr. Dummer recapped that the transition process will follow through as planned and presented on the merger Web site, which includes information regarding ongoing services, office logistics, and personnel decisions. Mr. Dummer also reported that both scientific journals--Journal for Biomolecular Screening (JBS) and Journal of the Association for Laboratory Automation (JALA)--would continue their publishing schedules.

Mr. Dummer remarked that later in 2010, members will notice two new enhancements as a result of the merger: a unique, cutting-edge provision for membership-by-contribution, and a robust internship program to help develop emerging scientific talent in the field of laboratory automation and screening.

The Society for Laboratory Automation and Screening mission is to be the preeminent global organization providing forums for education and information exchange to encourage the study of, and improve the science and practice of, laboratory automation and screening.

Related Links:
Society for Biomolecular Sciences
Association for Laboratory Automation
Society for Laboratory Automation and Screening


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.